welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

Myosana Therapeutics, Inc. Raises Up To $1M from CureDuchenne Ventures


Myosana Therapeutics, Inc., a new biotech company developing novel platform technology for non-viral gene delivery, raised up to $1M in seed financing from CureDuchenne Ventures. Myosana will use this initial funding to advance development of its innovative non-viral gene therapy to deliver full length dystrophin for Duchenne muscular dystrophy (DMD).

Myosana Therapeutics, Inc. Raises Up To $1M From CureDuchenne Ventures